Phase Ib clinical trial evaluating the safety, tolerability, pharmacokinetic and pharmacodynamic profile of ABP2111Na tablets in randomized, double-blind, placebo-controlled single and multiple administration dose escalation in patients with type 2 diabetes mellitus